TAYSHA GENE THERAPIES
RECEIVES RARE PEDIATRIC DISEASE
AND ORPHAN DRUG DESIGNATIONS
FOR SLC13A5 DEFICIENCY

Read Here

Check out our
2020 Updates!

Read Here

Newly diagnosed?

Join our registry!

Subscribe to Updates

TESS Research Foundation

​​Our Goal is to find treatments for the genetic disease SLC13A5 Deficiency.

TESS Research Foundation is a 501(c)(3) tax exempt public charity. Our mission is to help families affected by SLC13A5 Deficiency. SLC13A5 Deficiency (aka Citrate Transporter Disorder) is a newly discovered genetic cause of epilepsy, and as such, TESS Research Foundation is building a patient-centered network from the ground up. We are determined to diagnose, treat, and ultimately cure SLC13A5 Deficiency. We do this by funding cutting-edge research and connecting families, doctors, and researchers.

Tessa's Superhero Story

The Windisch Family's Experience with SLC13A5 Deficiency

/
by Nicole Windisch Our daughter Meredith Grace was born on…

How TESS Impacts the Wider Medical Community--by Deepti Dubey, PhD

/
Deepti Dubey, PhD is a Scientific Officer for TESS Research Foundation.…

Update from Dr. Brenda Porter, Scientific Advisory Board Member

/
I wanted to take a moment to update everyone on the TESS Research…

A Day in the Life of a Family Living with SLC13A5 - Grover Family

/
Maureen Grover and her husband, Hans, have three children, Landon,…

Tax Information

TESS Research Foundation

A 501(c)(3) nonprofit corporation

Tax ID Number: 47-3108868

Treatments for Epilepsy and Symptoms of SLC13A5

Contact Information

Kimberly Nye
655 Oak Grove Ave #53
Menlo Park, CA 94026

(650) 521-2279

E-Mail Kim